Enrollment Begins for Phase 2/3 Trial of Veradermics’s VDPHL01 in Female Pattern Hair Loss
Veradermics is enrolling women in its Phase 2/3 clinical trial of VDPHL01, an extended-release oral minoxidil treatment. VDPHL01 holds the potential to be the first non-hormonal oral treatment designed specifically for hair regrowth in women and men and the first-ever oral prescription treatment for women with pattern hair loss. The Phase 2/3 clinical trial (is […]